Author

C. R. Rickertsen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:imaging· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Assay:clinical cohort / trial· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

K. R. Swanson· 4 shared L. S. Hu· 4 shared S. K. Johnston· 4 shared A. B. Porter· 2 shared B. J. Anderies· 2 shared G. De Leon· 2 shared J. B. Rubin· 2 shared K. R. Clark-Swanson· 2 shared

Activity by Year

2018-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

K. R. Swanson

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Sex Differences in MRI-Based Metrics of Glioma Invasion and Brain Mechanics

B. J. Anderies, S. F. Yee, P. R. Jackson, C. R. Rickertsen, A. J. Hawkins-Daarud, S. K. Johnston, K. R. Clark-Swanson, J. M. Hoxworth, Y. Le, Y. Zhou, K. M. Pepin, S. C. Massey, L. S. Hu, J. R. Huston, K. R. Swanson

This study examines sex differences in MRI and MRE metrics related to glioma invasion and brain mechanics, finding sex-dependent relationships between tumor stiffness and growth parameters.

bioRxiv · Nov 21, 2020 · PreprintBiophysics

Days Gained Response Discriminates Treatment Response in Patients with Recurrent Glioblastoma Receiving Bevacizumab-based Therapies

K. W. Singleton, A. B. Porter, L. S. Hu, S. K. Johnston, K. M. Bond, C. R. Rickertsen, G. De Leon, S. A. Whitmire, K. R. Clark-Swanson, M. M. Mrugala, K. R. Swanson

This study evaluates Days Gained (DG) as a metric for assessing treatment response in recurrent glioblastoma patients receiving bevacizumab-based therapies, showing its prognostic significance for survival outcomes.

bioRxiv · Aug 30, 2019Cancer Biology

Sex differences in seizure at presentation in glioma population

S. Ranjbar, B. J. Anderies, K. W. Singleton, S. K. Johnston, C. R. Rickertsen, A. Sharma, A. B. Porter, M. M. Mrugala, L. S. Hu, J. R. Mitchell, J. B. Rubin, K. R. Swanson

This study examines the association between tumor location and seizure risk in male and female glioma patients.

bioRxiv · Aug 4, 2019 · PreprintCancer Biology

Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients

P. Whitmire, C. R. Rickertsen, A. Hawkins-Daarud, E. Carrasco, J. Lorence, G. De Leon, L. Curtin, S. Bayless, K. Clark-Swanson, N. C. Peeri, C. Corpuz, C. P. Lewis-de los Angeles, B. R. Bendok, L. Gonzalez-Cuyar, S. Vora, , K. R. Swanson

This study identifies sex-specific predictors of survival in glioblastoma patients using MR imaging and clinical data.

bioRxiv · Sep 25, 2018Cancer Biology